Logo

Abbott's BinaxNOW COVID-19 Ag Card Receives the US FDA's EUA to Detect SARS-CoV-2 Infection

Share this

Abbott's BinaxNOW COVID-19 Ag Card Receives the US FDA's EUA to Detect SARS-CoV-2 Infection

Shots:

  • The US FDA has issued EUA for Abbott’s BinaxNOW COVID-19 Ag Card rapid test for the detection of COVID-19. The test will be available at $5 and can deliver results in 15mins.
  • The test utilizes lateral flow technology and has demonstrated a sensitivity of 97.1% and specificity of 98.5% in a clinical study. Additionally- the company has launched the complementary phone app (NAVICA)- allowing people to display their BinaxNOW test results in any organizations where people gather like workplaces and schools
  • The BinaxNOW COVID-19 Ag Card can be used as a 1L of defense to identify infected people. The company anticipates shipping of ~10M tests in Sept- ramping to 50M tests/ month at the beginning of Oct’2020

­ Ref: Abbott | Image: Abbott

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions